قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ US futures recover after Trump weakens position in China trade with Reuters

US futures recover after Trump weakens position in China trade with Reuters




By Akanksha Rana

(Reuters) – US stock futures rose on Monday after US President Donald Trump moved to ease trade tensions with China, easing investor nerves after intense feuds between the two world's largest economies sent shares last week

The S&P 500 Index () registered its worst weekly loss on Friday after a sell-off at the end of May after both sides threatened to cut more tariffs on the other's and Trump's goods told the american comp to seek alternatives to doing business with China.

In a change in position, Trump said on Monday that Beijing had contacted Washington overnight to say it wanted to return to the negotiating table.

Shares of tariff-sensitive shares, including Apple Inc (O 🙂 and Boeing Co (N 🙂 rose more than 1

.5% each in pre-sale trading.

Chip makers, which rely heavily on China for their revenue, have also grown in early trade. Intel Corp (O :), Qualcomm Inc (O :), Advanced Micro Devices Inc (O 🙂 and Nvidia Corp (O 🙂 were up between 1.4% and 3%.

Concerns about the world economy plunging into recession and uncertainty about the rate of decline in interest rates in the United States have caused investors to wonder how far the longest US enlargement cycle can go. The S&P 500 closed about 6% of its record high on Friday.

However, a batch of strong retail revenue from those including Walmart Inc (N 🙂 and Target Corp (N 🙂 in the past week have boosted confidence in internal growth.

Data from the Commerce Department, due out at 08:30 ET (12:30 GMT), may indicate that general orders for durable goods increased by 1.2% in July, after an increase of 1.9% in June.

At 7:29 PM ET, they were up 200 points or 0.78%. The S&P 500 electronic mines increased by 17 points or 0.6% and by 62.75 points or 0.84%.

Among other stocks, Celgene Corp (O 🙂 rose 3.7% after Amgen Inc (O 🙂 said on Monday it would buy psoriasis medicine for the company Otezla, clearing the way for Bristol-Myers Squibb (N 🙂 to move forward with its $ 74 billion deal for Celgene. Bristol-Myers shares jumped 5.7%.

Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by stock exchanges, but rather by market producers, so prices may not be accurate and may differ from the actual market price, which means that prices are indicative and are not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses that you may incur as a result of using this data.

Fusion Media or anyone participating in Fusion Media assumes no responsibility for any loss or damage resulting from the reading of the information, including data, quotes, schedules, and buy / sell signals contained on this website Please be fully informed about the risks and costs involved in trading in the financial markets, this is one of the most risky investment options available.


Source link